{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:56:54Z","timestamp":1785473814890,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["EU RIA 733161"],"award-info":[{"award-number":["EU RIA 733161"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["WISDOM RIA 101137154"],"award-info":[{"award-number":["WISDOM RIA 101137154"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390857198"],"award-info":[{"award-number":["390857198"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008659","name":"European Committee for Treatment and Research in Multiple Sclerosis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["GA 2913\/3-1"],"award-info":[{"award-number":["GA 2913\/3-1"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ZZ1804"],"award-info":[{"award-number":["01ZZ1804"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["513308106"],"award-info":[{"award-number":["513308106"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["161L0216"],"award-info":[{"award-number":["161L0216"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.msard.2025.106366","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:31:08Z","timestamp":1740771068000},"page":"106366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Antibiotic drug use in the five years preceding the diagnosis of multiple sclerosis"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8155-8521","authenticated-orcid":false,"given":"Sonia","family":"Darvishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan","family":"Donnachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Anne","family":"Uibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Flaskamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Gasperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hapfelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5985-6784","authenticated-orcid":false,"given":"Bernhard","family":"Hemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2025.106366_bib0016","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ane.12958","article-title":"Infectious exposure, antibiotic use, and multiple sclerosis: a population-based incident case-control study","volume":"138","author":"Abdollahpour","year":"2018","journal-title":"Acta Neurol. Scand."},{"issue":"11","key":"10.1016\/j.msard.2025.106366_bib0019","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/aje\/kwj123","article-title":"Antibiotic use and risk of multiple sclerosis","volume":"163","author":"Alonso","year":"2006","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.msard.2025.106366_bib0018","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000515682","article-title":"Antibiotic use and risk of multiple sclerosis: a nested case-control study in Emilia-Romagna Region, Italy","volume":"55","author":"Baldin","year":"2021","journal-title":"Neuroepidemiology."},{"issue":"1","key":"10.1016\/j.msard.2025.106366_bib0009","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"issue":"6578","key":"10.1016\/j.msard.2025.106366_bib0004","first-page":"296","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science (1979)"},{"key":"10.1016\/j.msard.2025.106366_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.946248","article-title":"Gut microbiota, leaky Gut, and autoimmune diseases","volume":"13","author":"Christovich","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.msard.2025.106366_bib0029","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106366_bib0014","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.msard.2025.106366_bib0024","series-title":"Annual Epidemiological Report","article-title":"Antimicrobial consumption in the EU\/EEA (ESAC-Net) -&nbsp","year":"2020"},{"issue":"1","key":"10.1016\/j.msard.2025.106366_bib0006","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12974-020-01766-9","article-title":"Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease","volume":"17","author":"G\u00f6del","year":"2020","journal-title":"J. Neuroinflammation."},{"issue":"24","key":"10.1016\/j.msard.2025.106366_bib0021","doi-asserted-by":"crossref","first-page":"e2977","DOI":"10.1212\/WNL.0000000000012074","article-title":"Systematic assessment of medical diagnoses preceding the first diagnosis of multiple sclerosis","volume":"96","author":"Gasperi","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106366_bib0027","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012074","article-title":"Systematic assessment of medical diagnoses preceding the first diagnosis of multiple sclerosis","author":"Gasperi","year":"2021","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.msard.2025.106366_bib0030","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4049\/jimmunol.1601621","article-title":"Host-microbiota interactions shape local and systemic inflammatory diseases","volume":"198","author":"Grigg","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2025.106366_bib0013","doi-asserted-by":"crossref","first-page":"e7502","DOI":"10.7717\/peerj.7502","article-title":"Factors affecting the composition of the gut microbiota, and its modulation","volume":"7","author":"Hasan","year":"2019","journal-title":"PeerJ."},{"issue":"9","key":"10.1016\/j.msard.2025.106366_bib0028","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41582-022-00686-x","article-title":"From the prodromal stage of multiple sclerosis to disease prevention","volume":"18","author":"Marrie","year":"2022","journal-title":"Nat. Rev. Neurol"},{"issue":"8","key":"10.1016\/j.msard.2025.106366_bib0020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/aje\/kwr201","article-title":"Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study","volume":"174","author":"N\u00f8rgaard","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.msard.2025.106366_bib0012","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fmicb.2017.01388","article-title":"Ontogenesis of the gut microbiota composition in healthy, full-term, vaginally born and breast-fed infants over the first 3 years of life: a quantitative bird's-eye view","volume":"8","author":"Nagpal","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.msard.2025.106366_bib0011","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12866-016-0708-5","article-title":"Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study","volume":"16","author":"Odamaki","year":"2016","journal-title":"BMC. Microbiol."},{"issue":"1","key":"10.1016\/j.msard.2025.106366_bib0002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2025.106366_bib0017","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1080\/03007995.2017.1325575","article-title":"Allergies, antibiotics use, and multiple sclerosis","volume":"33","author":"Ren","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.msard.2025.106366_bib0022","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fneur.2019.00188","article-title":"Impact of the McDonald criteria 2017 on early diagnosis of relapsing-remitting multiple sclerosis","volume":"10","author":"Schwenkenbecher","year":"2019","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2025.106366_bib0008","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/ajg.2010.398","article-title":"Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease","volume":"105","author":"Shaw","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.msard.2025.106366_bib0026","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1177\/13524585231185045","article-title":"Exposure to systemic antibiotics in outpatient care and the risk of multiple sclerosis","volume":"29","author":"Sipil\u00e4","year":"2023","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2025.106366_bib0015","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.21873\/invivo.12186","article-title":"Dominant antibiotic consumption patterns might Be associated with the prevalence of multiple sclerosis in European countries","volume":"34","author":"Tern\u00c1k","year":"2020","journal-title":"In. Vivo (Brooklyn)"},{"issue":"1","key":"10.1016\/j.msard.2025.106366_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-022-01148-1","article-title":"The gut microbiota in multiple sclerosis varies with disease activity","volume":"15","author":"Thirion","year":"2023","journal-title":"Genome Med."},{"issue":"10130","key":"10.1016\/j.msard.2025.106366_bib0003","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.msard.2025.106366_bib0007","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/ajg.2014.246","article-title":"Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis","volume":"109","author":"Ungaro","year":"2014","journal-title":"Am. J. Gastroenterol."},{"issue":"14","key":"10.1016\/j.msard.2025.106366_bib0001","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.msard.2025.106366_bib0025","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/1352458518783662","article-title":"Five years before multiple sclerosis onset: phenotyping the prodrome","volume":"25","author":"Wijnands","year":"2019","journal-title":"Multiple Sclerosis J"},{"key":"10.1016\/j.msard.2025.106366_bib0023","series-title":"Bundesamt F\u00fcr Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e V(eds)","article-title":"Antibiotikaverbrauch im ambulanten Bereich","author":"Zeidan","year":"2012"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:29:19Z","timestamp":1778840959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":30,"alternative-id":["S2211034825001099"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106366","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic drug use in the five years preceding the diagnosis of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106366"}}